Clinical Trial

Exploratory Clinical Study on the Safety of STR-P004

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 9, 2026 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is an open-label, multiple-dose escalation IIT clinical study aimed at evaluating the safety, tolerability, PK, and preliminary efficacy of STR-P004 in adult patients with relapsed or refractory autoimmune diseases.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-20; most recent amendment 2026-03-05.
Status change: Not Yet Recruiting → Recruiting 2026-03-05
Trial Details
NCT Number NCT07143617
Lead Sponsor Beijing GoBroad Hospital
Collaborators: Starna Therapeutics
Conditions Autoimmune Diseases
Enrollment 39 participants
Start Date 2025-09-16
Primary Completion 2026-08-15 (estimated)
Study Completion 2026-09-14 (estimated)
Updated on ClinicalTrials.gov 2026-03-09